Abstract:BACKGROUND: Multipotential stem cells exist in bone marrow. With the abilities to multiple direction and homing, these stem cells have become the studying direction for the research of various disease treatments. OBJECTIVE: To observe the therapeutic efficacy of bone marrow stem cell mobilization with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rats with acute myocardial infarction, and to certificate the selectivity in stem cells homing ischemic myocardium, and to evaluate short-term security. DESIGN, TIME AND SETTING: The randomized, controlled animal study was performed at the Laboratory of Pathology and Physiology, Basic Medical College, Jinlin University from September 2006 to April 2007. MATERIALS: A total of 82 clean Sprague Dawley rats, of both gender, weighing 250-300 g, were selected. Of them, 62 rats were made into acute myocardial infarction models by ligating anterior descending coronary artery, and 20 rats served as the sham operation group. METHODS: A total of 41 successful rat models were divided into a model group (n=20) and a mobilization group (n =21). Rats in the model group underwent subcutaneously saline (2 mL/d) for 7 days. Rats in the mobilization group underwent subcutaneously rhG-CSF 15 μg/(kg·d) and saline (2.5 mg/L) for 7 days. Rats in the sham operation group received braid at the coronary artery ligation site, no deligatin, and other procedures were similar, subcutaneous injection of saline (2 mL/d), for 7 days. MAIN OUTCOME MEASURES: One week later, percentage of rat peripheral blood leucocytes and mononuclear cells was counted in each group. Heart function was compared among groups 4 weeks later. Rat heart, lung, liver and skeletal muscle tissues were obtained, sectioned, and subjected to hematoxylin-eosin staining and CD34 immunohistochemistry to observe pathological changes in heart tissues, capillary density and CD34+ cell homing. RESULTS: One week later, in the mobilization group, the peripheral blood leukocytes and mononuclear cells increased obviously compared with that before mobilization (P < 0.05). Rat peripheral blood leukocyte counting and micronucleated cell rate were significantly greater in the mobilization group than in the model group (P < 0.05). At week 1, there were a great number of monocytes infiltrating with CD34 expression in the rat myocardial infracted zone in the mobilization group compared with the model group (P < 0.05). At week 4, there was no CD34 expression in both mobilization group and model group. No significant differences were found in the rat liver, lung and skeletal muscle at various time points. Four weeks after model establishment, various indexes of heart function were better (P < 0.05), and infarcted area was less (P < 0.05), and capillary density was significantly higher (P < 0.05) in the mobilization group compared with the model group. CONCLUSION: The rhG-CSF can mobilize bone marrow stem cells to home to infracted zones and differentiate to cardiomyocyte-like cells and capillary endothelium cells in rats following myocardial infarction. Thus, myocardial infarcted range was reduced and heart function was improved. Short-term observation of rhG-CSF has no significant histology effects on the lung, liver and skeletal muscle.

A Novel Approach To Mobilize Bone Marrow Stem Cells With Cxcr4 Expression For Enhanced Tissue Repair In Rat Cardiac Allograft

Optimal Temporal Delivery of Bone Marrow Mesenchymal Stem Cells in Rats with Myocardial Infarction.

Abstract 19996: Cardiac Mesenchymal Stem Cells with High Endogenous Gata4 Promoter Activity Have Superior Capacity to Elicit Cardiac Repair

Angiotensin Receptor Type 2 Stimulation Increases the Migration of Bone-Marrow Mononuclear Cells into the Infarcted Myocardium and Improves Heart Function

Short-term safety in mobilizing autologus bone marrow stem cells homing to ischemic myocardium using recombinant human granulocyte colony-stimulating factor in acute myocardial ischemia rats

C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.

Evidence for Ischemia Induced Host-Derived Bone Marrow Cell Mobilization into Cardiac Allografts

Treatment of Acute Myocardial Infarction with Autologous Bone Marrow Stem Cells Mobilization Combined with Recombinant Growth Factor in Rat

Targeted Migration of Mesenchymal Stem Cells Modified with CXCR4 Gene to Infarcted Myocardium Improves Cardiac Performance

Effect of autologous bone stem cell transplant mobilized by colony-stimulating factor on chronic cardiac failure rats with myocardial infarction

Abstract 16620: Enhancing Transplanted Cardiac Progenitor Cells Homing and Survival in Ischemic Heart by CRISPR-dcas9/sgRNA-based Endogenous CXCR4 Promoter Activation

Stem Cell Homing and Angiomyogenesis in Transplanted Hearts Are Enhanced by Combined Intramyocardial Sdf-1 Alpha Delivery and Endogenous Cytokine Signaling

[Transplantation of Bone Marrow Cells Upregulated Vascular Endothelial Growth Factor and Its Receptor and Improved Ischemic Myocardial Function].

Transmyocardial Revascularization Enhances Bone Marrow Stem Cell Engraftment in Infarcted Hearts Through SCF-C-kit and SDF-1-CXCR4 Signaling Axes

The Effect of Bone Marrow Stem Cells Mobilization on Cardiac Performance of Acute Myocardial Infarction Rats

Transplantation of marrow-derived cardiac stem cells carried in designer self-assembling peptide nanofibers improves cardiac function after myocardial infarction.

Improvement of Cardiac Function by Transplanting Autologous Mononuclear Bone Marrow Cells into Myocardial Infarction Scar and the Periphery

P4.12 EGRESS OF FUNCTIONALLY COMPETENT PROGENITOR CELLS OVER-EXPRESSING CXCR4 FROM THE BONE MARROW FOLLOWING CARDIAC SURGERY WITH THE USE OF CARDIOPULMONARY BYPASS

Combining Pharmacological Mobilization with Intramyocardial Delivery of Bone Marrow Cells Over-Expressing VEGF is More Effective for Cardiac Repair.

[Effects of Marrow-Derived Cardiac Stem Cell Transplantation after Myocardial Infarction in Rats].

Cellular Transplant Applied with Rat Bone Marrow Stromal Cells Preconditioned with Stromal-Derived Factor 1 to Treat Acute Myocardial Infarction